Discovery of a metabolic signature predisposing high risk patients with mild cognitive impairment to converting to alzheimer’s disease

Yi Long Huang, Chao Hsiung Lin, Tsung Hsien Tsai, Chen Hua Huang, Jie Ling Li, Liang Kung Chen, Chun Hsien Li, Ting Fen Tsai*, Pei Ning Wang

*此作品的通信作者

研究成果: Article同行評審

3 引文 斯高帕斯(Scopus)

摘要

Assessing dementia conversion in patients with mild cognitive impairment (MCI) remains challenging owing to pathological heterogeneity. While many MCI patients ultimately proceed to Alzheimer’s disease (AD), a subset of patients remain stable for various times. Our aim was to characterize the plasma metabolites of nineteen MCI patients proceeding to AD (P-MCI) and twentynine stable MCI (S-MCI) patients by untargeted metabolomics profiling. Alterations in the plasma metabolites between the P-MCI and S-MCI groups, as well as between the P-MCI and AD groups, were compared over the observation period. With the help of machine learning-based stratification, a 20-metabolite signature panel was identified that was associated with the presence and progression of AD. Furthermore, when the metabolic signature panel was used for classification of the three patient groups, this gave an accuracy of 73.5% using the panel. Moreover, when specifically classifying the P-MCI and S-MCI subjects, a fivefold cross-validation accuracy of 80.3% was obtained using the random forest model. Importantly, indole-3-propionic acid, a bacteria-generated metabolite from tryptophan, was identified as a predictor of AD progression, suggesting a role for gut microbiota in AD pathophysiology. Our study establishes a metabolite panel to assist in the stratification of MCI patients and to predict conversion to AD.

原文English
文章編號10903
期刊International Journal Of Molecular Sciences
22
發行號20
DOIs
出版狀態Published - 1 10月 2021

指紋

深入研究「Discovery of a metabolic signature predisposing high risk patients with mild cognitive impairment to converting to alzheimer’s disease」主題。共同形成了獨特的指紋。

引用此